Raphaël Duval

Prof. Dr. Raphaël Duval

University of Lorraine, Nancy, Grand Est, France
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2018 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
PDF file
MVMarin Vincent
Marin Vincent
Raphaël DuvalRaphaël Duval
Raphaël Duval
PHPhilippe Hartemann
Philippe Hartemann
MEMarc Engels-Deutsch
Marc Engels-Deutsch

27 April 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
ASAlexis Simons
Alexis Simons
KAKamel Alhanout
Kamel Alhanout
Raphaël DuvalRaphaël Duval
Raphaël Duval
Currently, the emergence and ongoing dissemination of antimicrobial resistance among bacteria are critical health and economic issue, leading to increased rates of morbidity and mortality related to bacterial infections. Research and development for new antimicrobial agents is currently needed to overcome this problem. Among the different approaches studied, bacteriocins seem to be a promising possibility. These molecules are peptides naturally synthesized by ribosomes, produced by both Gram-positive bacteria (GPB) and Gram-negative bacteria (GNB), which will allow these bacteriocin producers to survive in highly competitive polymicrobial environment. Bacteriocins exhibit antimicrobial activity with variable spectrum depending on the peptide, which may target several bacteria. Already used in some areas such as agro-food, bacteriocins may be considered as interesting candidates for further development as antimicrobial agents used in health contexts, particularly considering the issue of antimicrobial resistance. The aim of this review is to present an updated global report on the biology of bacteriocins produced by GPB and GNB, as well as their antibacterial activity against relevant bacterial pathogens, and especially against multidrug-resistant bacteria.

12 November 2012 in Viruses
Verified
Journal Article
Open access
PDF file
CGChloé Geller
Chloé Geller
Mihayl VarbanovMihayl Varbanov
Mihayl Varbanov
Raphaël DuvalRaphaël Duval
Raphaël Duval
The Coronaviridae family, an enveloped RNA virus family, and, more particularly, human coronaviruses (HCoV), were historically known to be responsible for a large portion of common colds and other upper respiratory tract infections. HCoV are now known to be involved in more serious respiratory diseases, i.e. bronchitis, bronchiolitis or pneumonia, especially in young children and neonates, elderly people and immunosuppressed patients. They have also been involved in nosocomial viral infections. In 2002–2003, the outbreak of severe acute respiratory syndrome (SARS), due to a newly discovered coronavirus, the SARS-associated coronavirus (SARS-CoV); led to a new awareness of the medical importance of the Coronaviridae family. This pathogen, responsible for an emerging disease in humans, with high risk of fatal outcome; underline the pressing need for new approaches to the management of the infection, and primarily to its prevention. Another interesting feature of coronaviruses is their potential environmental resistance, despite the accepted fragility of enveloped viruses. Indeed, several studies have described the ability of HCoVs (i.e. HCoV 229E, HCoV OC43 (also known as betacoronavirus 1), NL63, HKU1 or SARS-CoV) to survive in different environmental conditions (e.g. temperature and humidity), on different supports found in hospital settings such as aluminum, sterile sponges or latex surgical gloves or in biological fluids. Finally, taking into account the persisting lack of specific antiviral treatments (there is, in fact, no specific treatment available to fight coronaviruses infections), the Coronaviridae specificities (i.e. pathogenicity, potential environmental resistance) make them a challenging model for the development of efficient means of prevention, as an adapted antisepsis-disinfection, to prevent the environmental spread of such infective agents. This review will summarize current knowledge on the capacity of human coronaviruses to survive in the environment and the efficacy of well-known antiseptic-disinfectants against them, with particular focus on the development of new methodologies to evaluate the activity of new antiseptic-disinfectants on viruses.

14 February 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
NMNour Mammari
Nour Mammari
ELEmmanuel Lamouroux
Emmanuel Lamouroux
ABariane boudier
ariane boudier
Raphaël DuvalRaphaël Duval
Raphaël Duval
The emergence of multidrug-resistant (MDR) bacteria in recent years has been alarming and represents a major public health problem. The development of effective antimicrobial agents remains a key challenge. Nanotechnologies have provided opportunities for the use of nanomaterials as components in the development of antibacterial agents. Indeed, metal-based nanoparticles (NPs) show an effective role in targeting and killing bacteria via different mechanisms, such as attraction to the bacterial surface, destabilization of the bacterial cell wall and membrane, and the induction of a toxic mechanism mediated by a burst of oxidative stress (e.g., the production of reactive oxygen species (ROS)). Considering the lack of new antimicrobial drugs with novel mechanisms of action, the induction of oxidative stress represents a valuable and powerful antimicrobial strategy to fight MDR bacteria. Consequently, it is of particular interest to determine and precisely characterize whether NPs are able to induce oxidative stress in such bacteria. This highlights the particular interest that NPs represent for the development of future antibacterial drugs. Therefore, this review aims to provide an update on the latest advances in research focusing on the study and characterization of the induction of oxidative-stress-mediated antimicrobial mechanisms by metal-based NPs.

1 November 2008 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SFStéphane Fontanay
Stéphane Fontanay
MGMarion Grare
Marion Grare
JMJoséphine Mayer
Joséphine Mayer
CFChantal Finance
Chantal Finance
Raphaël DuvalRaphaël Duval
Raphaël Duval

1 May 2013 in Micron
Verified
Journal Article
Closed access
LCL. Chopinet
L. Chopinet
CFCécile Formosa-Dague
Cécile Formosa-Dague
Marie-Pierre RolsMarie-Pierre Rols
Marie-Pierre Rols
Raphaël DuvalRaphaël Duval
Raphaël Duval
EDEtienne Dague
Etienne Dague